Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more) Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Bristol-Myers Squibb Co BMY

Healthcare
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule... see more

Opinion & Analysis (NYSE:BMY)

    Big pharma sets its sights on NASH epidemic

    The Life Sciences Report May 18, 2017

    Use stock volatility to invest in innovative oncology companies: JMP Security's Michael King Jr.

    Gail Dutton October 15, 2015

    Opportunities in cancer immunotherapy throttle up: George Zavoico of JonesTrading

    George S. Mack June 25, 2015

    U.S. Tech, Dollar & Health Care ETFs To Watch This Week

    Benzinga.com  April 26, 2015

    Drug ETFs Attractive Buys On Pullback

    Benzinga.com  October 22, 2014

    Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary

    Benzinga.com  July 30, 2014

    ETF Outlook For Tuesday, April 29, 2014 (IHE, TAN, XRT, SOCL, TWTR)

    Benzinga.com  April 29, 2014

    Big Pharma has a big problem and merger mania is heating up

    Marc Lichtenfeld July 29, 2010

    Charging lithium company

    Thom Calandra July 29, 2009